Feenstra TL - Search Results

1

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis.

Suijkerbuijk AWM, Over EAB, Opsteegh M, Deng H, Gils PFV, Bonačić Marinović AA, Lambooij M, Polder JJ, Feenstra TL, Giessen JWBV, Wit GA, Mangen MJ. Suijkerbuijk AWM, et al. Among authors: feenstra tl. PLoS One. 2019 May 10;14(5):e0216615. doi: 10.1371/journal.pone.0216615. eCollection 2019. PLoS One. 2019. PMID: 31075130 Free PMC article.

2

Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.

Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MP. Feenstra TL, et al. Value Health. 2005 May-Jun;8(3):178-90. doi: 10.1111/j.1524-4733.2005.04008.x. Value Health. 2005. PMID: 15877590 Free article.

3

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.

Vijgen SM, van Baal PH, Hoogenveen RT, de Wit GA, Feenstra TL. Vijgen SM, et al. Among authors: feenstra tl. Health Educ Res. 2008 Apr;23(2):310-8. doi: 10.1093/her/cym024. Epub 2007 Aug 4. Health Educ Res. 2008. PMID: 17675649

4

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.

van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. PLoS Med. 2008 Feb;5(2):e29. doi: 10.1371/journal.pmed.0050029. PLoS Med. 2008. PMID: 18254654 Free PMC article.

5

Economic evaluation and the postponement of health care costs.

van Baal PH, Feenstra TL, Polder JJ, Hoogenveen RT, Brouwer WB. van Baal PH, et al. Among authors: feenstra tl. Health Econ. 2011 Apr;20(4):432-45. doi: 10.1002/hec.1599. Health Econ. 2011. PMID: 21210494

6

[Societal costs of asthma, COPD and respiratory allergy].

Suijkerbuijk AW, de Wit GA, Wijga AH, Heijmans M, Hoogendoorn M, Rutten-van Mölken M, Maurits EE, Hoogenveen RT, Feenstra TL. Suijkerbuijk AW, et al. Among authors: feenstra tl. Ned Tijdschr Geneeskd. 2013;157(46):A6562. Ned Tijdschr Geneeskd. 2013. PMID: 24220178 Dutch.

7

Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness.

Over EA, Feenstra TL, Hoogenveen RT, Droomers M, Uiters E, van Gelder BM. Over EA, et al. Among authors: feenstra tl. Nicotine Tob Res. 2014 Jun;16(6):725-32. doi: 10.1093/ntr/ntt218. Epub 2014 Jan 4. Nicotine Tob Res. 2014. PMID: 24388862

8

Reply to the comment by Van der Deen et al.: "Possible methodological reason for the finding that 'Neither tax increase nor reimbursement reduced health disparities'".

Over EA, Feenstra TL, Hoogenveen RT, Droomers M, Uiters E, van Gelder BM. Over EA, et al. Among authors: feenstra tl. Nicotine Tob Res. 2014 Jul;16(7):1031-2. doi: 10.1093/ntr/ntu068. Epub 2014 Apr 23. Nicotine Tob Res. 2014. PMID: 24759894 No abstract available.

9

[Costs and benefits of smoking].

Polder JJ, van Gils PF, Kok L, Talhout R, Feenstra TL. Polder JJ, et al. Among authors: feenstra tl. Ned Tijdschr Geneeskd. 2017;160:D833. Ned Tijdschr Geneeskd. 2017. PMID: 28181894 Dutch.

10

The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach.

Suijkerbuijk AWM, van Gils PF, Bonačić Marinović AA, Feenstra TL, Kortbeek LM, Mangen MJ, Opsteegh M, de Wit GA, van der Giessen JWB. Suijkerbuijk AWM, et al. Among authors: feenstra tl. Zoonoses Public Health. 2018 Feb;65(1):185-194. doi: 10.1111/zph.12417. Epub 2017 Nov 12. Zoonoses Public Health. 2018. PMID: 29131528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page